Elizabeth Schmidt is a Scientific Leader at GSK within the R&D CMC Analytical Development organization. She’s worked in many roles within biopharmaceutical CMC analytical including QC bench analyst focused on ELISA and HPLC techniques, a method developer with a concentration on GMP ready analytics, and as an analytical CMC project matrix team leader. In her current role she leads a team of analytical CMC Matrix leaders who support biopharmaceutical projects from candidate selection through first commercial launch. In addition, she chairs a Comparability Specialist Sign Off Group within the CMC Governance structure that is accountable for endorsement of CMC comparability strategy for projects in the GSK portfolio.